Korea&#39;s Ministry of Food and Drug Safety has expanded the label for Prevymis, an antiviral known generically as letermovir, to include pediatric use for preventing cytomegalovirus (CMV) infection and disease, MSD Korea said Tuesday.

Prevymis (letermovir) - Merck (MSD)

Oct 14, 2025